I continue to be puzzled how often seasoned physicians prescibe relatively new drugs soon after their introduction. Crestor certainly looked good ( marked lowering of LDl, seemed to offer the muscle safety of Pravachol and less concern with interactions) and for the most part still does but FDA has issued a
warning and wants us to know that 1) you have to use less in Asians and 2) there may be something to the kidney toxicity issue .
Never be the first, never be the last is my motto with new drugs.
ReplyDeleteNice blog, BTW!